Your browser doesn't support javascript.
Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
Talamonti, M; Tofani, L; Bianchi, L; Galluzzo, M.
  • Talamonti M; Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy. talamonti.marina@gmail.com.
  • Tofani L; Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. talamonti.marina@gmail.com.
  • Bianchi L; Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy.
  • Galluzzo M; Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
Arch Dermatol Res ; 313(2): 127-128, 2021 03.
Article in English | MEDLINE | ID: covidwho-1064476

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / Practice Guidelines as Topic / Withholding Treatment / Cytokine Release Syndrome / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Arch Dermatol Res Year: 2021 Document Type: Article Affiliation country: S00403-020-02103-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / Practice Guidelines as Topic / Withholding Treatment / Cytokine Release Syndrome / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Arch Dermatol Res Year: 2021 Document Type: Article Affiliation country: S00403-020-02103-z